Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2
Hai Li(Karolinska Institutet), Galina Selivanova(Karolinska Institutet), Klas Kärre(Karolinska Institutet), Cinzia Garofalo(Magna Graecia University), Clemens Spinnler(Magna Graecia University), Ennio Carbone(Karolinska Institutet), László Székely(Karolinska University Hospital), Martin Enge(Karolinska Institutet), Tadepally Lakshmikanth(Hammersmith Hospital), Andrea Anichini(University of Milan)
Cited by 118